Cost-effectiveness analysis of low density lipoprotein cholesterol-lowering therapy in hypertensive patients with type 2 diabetes in Korea: single-pill regimen (amlodipine/atorvastatin) versus double-pill regimen (amlodipine+atorvastatin)-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of low density lipoprotein cholesterol-lowering therapy in hypertensive patients with type 2 diabetes in Korea: single-pill regimen (amlodipine/atorvastatin) versus double-pill regimen (amlodipine+atorvastatin)

Published:2015-02-22 Issue: Volume:37 Page:e2015010
ISSN:2092-7193
Container-title:Epidemiology and Health
language:en
Short-container-title:Epidemiol Health

Author:

Park Ji-Hyun,Lee Yong-Ho,Ko Su-Kyoung,Cha Bong-Soo

Publisher

Korean Society of Epidemiology

Subject

General Medicine

Link

http://www.e-epih.org/upload/pdf/epih-37-e2015010.pdf

Reference31 articles.

1. Primary Prevention of Coronary Heart Disease: Guidance From Framingham

2. Therapeutic Goal Attainment in Patients With Hypertension and Dyslipidemia

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Benefit of Fixed‐Dose Combination of Amlodipine and Potent Atorvastatin in Patients With Concomitant Hypertension and Hypercholesterolemia;Journal of the American Heart Association;2024-05-07

2. Beneficial Effects of Fixed-Dose Combination of Amlodipine and Atorvastatin in Patients with Concomitant Hypertension and Hypercholesterolemia: A Multi-Institutional Cohort Study;ACTA CARDIOL SIN;2022

3. Basics of Polypharmacology;Polypharmacology;2022

4. Bempedoic acid for high-risk patients with CVD as adjunct lipid-lowering therapy: A cost-effectiveness analysis;Journal of Clinical Lipidology;2020-11

5. Fixed‐dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia;The Journal of Clinical Hypertension;2020-08-29